Sunitinib and Dermatologic toxicities
Result of checking the interaction of drug Sunitinib and disease Dermatologic toxicities for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Cutaneous reactions, in some cases severe, have been reported with the use of sunitinib. Monitor patients who develop dermatologic or soft tissue toxicities while receiving this agent. It is recommended to withhold treatment, and appropriate measures should be instituted as appropriate or discontinue the use of this agent for dermatologic or soft tissue toxicity associated with severe or life-threatening complications. If a diagnosis of Stevens-Johnson syndrome or toxic epidermal necrolysis is suspected treatment with sunitinib must not be re-started.
Sunitinib - toksyczność dermatologiczna 
Sunitinib - toxicidades dermatológicas 
Sunitinib - ketoksikan dermatologi 
Sunitinib - toksisitas dermatologis 
Sunitinib - tossicità dermatologiche 
Sunitinib - toxicités dermatologiques 
Sunitinib - dermatologische Toxizitäten 
Sunitinib - toxicidades dermatológicas 
Sunitinib - дерматологическая токсичность 
Sunitinib - dermatolojik toksisiteler 
Sunitinib - السمية الجلدية 
Sunitinib - 皮肤毒性